Publications found:
123
Sort by:
Global Biopharmaceutical CDMO Market Size Study and Forecast by Type (API, Finished Drug Product), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy Products, Cell Therapy Products, Others), Service (Process Development, Analytical Testing, Manufacturing Services, Fill-Finish Services, Packaging & Labeling), Source (Mammalian Cells, Microbial Systems, Yeast Systems, Insect Cells, Others), Workflow (Upstream Processing, Downstream Processing, Fill-Finish Operations), Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Neurological Disorders, Others), End Use (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Others), and Regional Forecasts 2026-2035
US$ 3,750.00
The global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) market encompasses third-party service providers that support biotechnology and pharmaceutical companies in the...
April 2026
285 pages
Asia Pacific Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Asia Pacific Biopharmaceutical Contract Manufacturing Market is poised for remarkable growth, projected to reach approximately US$ 26,544.2 million by 2031, up from US$ 10,448.9 million in 2024. T...
March 2026
176 pages
Europe Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Europe Biopharmaceutical Contract Manufacturing Market is projected to grow significantly, reaching an estimated US$ 27,678.2 million by 2031, up from US$ 11,420.5 million in 2024. This growth ref...
March 2026
177 pages
Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Middle East & Africa Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating an increase from US$ 875.4 million in 2024 to US$ 1,655.0 million...
March 2026
168 pages
North America Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The North America Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating it will reach approximately US$ 41,018.6 million by 2031, up from US$ 16...
March 2026
162 pages
South & Central America Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The South & Central America Biopharmaceutical Contract Manufacturing Market is poised for significant growth, with projections indicating an increase from US$ 1,766.4 million in 2024 to US$ 4,155.6 mi...
March 2026
168 pages